PL4029505T3 - Zastrzyk zawierający p-boronofenyloalaninę - Google Patents

Zastrzyk zawierający p-boronofenyloalaninę

Info

Publication number
PL4029505T3
PL4029505T3 PL20863900.5T PL20863900T PL4029505T3 PL 4029505 T3 PL4029505 T3 PL 4029505T3 PL 20863900 T PL20863900 T PL 20863900T PL 4029505 T3 PL4029505 T3 PL 4029505T3
Authority
PL
Poland
Prior art keywords
boronophenylalanine
injection containing
injection
Prior art date
Application number
PL20863900.5T
Other languages
English (en)
Inventor
Yoshiya IGUCHI
Yoshimitsu Katakuse
Hideki Nakashima
Original Assignee
Stella Pharma Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stella Pharma Corporation filed Critical Stella Pharma Corporation
Publication of PL4029505T3 publication Critical patent/PL4029505T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/69—Boron compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/009—Neutron capture therapy, e.g. using uranium or non-boron material
    • A61K41/0095—Boron neutron capture therapy, i.e. BNCT, e.g. using boronated porphyrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PL20863900.5T 2019-09-12 2020-09-09 Zastrzyk zawierający p-boronofenyloalaninę PL4029505T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2019165979 2019-09-12
PCT/JP2020/034086 WO2021049520A1 (ja) 2019-09-12 2020-09-09 p-ボロノフェニルアラニンを含有する注射液剤

Publications (1)

Publication Number Publication Date
PL4029505T3 true PL4029505T3 (pl) 2025-08-04

Family

ID=74865709

Family Applications (1)

Application Number Title Priority Date Filing Date
PL20863900.5T PL4029505T3 (pl) 2019-09-12 2020-09-09 Zastrzyk zawierający p-boronofenyloalaninę

Country Status (12)

Country Link
US (1) US12343354B2 (pl)
EP (1) EP4029505B1 (pl)
JP (2) JPWO2021049520A1 (pl)
KR (1) KR20220062367A (pl)
CN (1) CN114423458A (pl)
AR (1) AR119936A1 (pl)
AU (1) AU2020347682B2 (pl)
CA (1) CA3151009A1 (pl)
ES (1) ES3024982T3 (pl)
PL (1) PL4029505T3 (pl)
TW (1) TWI905111B (pl)
WO (1) WO2021049520A1 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2024132863A (ja) * 2023-03-14 2024-10-01 禾榮科技股▲フン▼有限公司 ホウ素錯体含有凍結乾燥粉末及びその形成方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5179619A (en) 1974-04-22 1976-07-12 Yutaka Kawano Kyujokokuenchutetsu no seizohoho
US5157149A (en) 1991-06-04 1992-10-20 The United States Of America As Represented By The United States Department Of Energy Enantioselective synthesis of L-(-)-4- boronophenylalanine (L-BPA)
US5492900A (en) 1993-09-10 1996-02-20 Neutron Technology Corporation Method for enhancing the solubility of the boron delivery drug, boronophenylalanine (BPA)
JP2979139B2 (ja) 1998-03-11 1999-11-15 東北大学長 L−パラボロノフェニルアラニンの製造方法
JP2000212185A (ja) 1999-01-14 2000-08-02 Ajinomoto Co Inc パラボロノフェニルアラニン誘導体の製造方法
US6169076B1 (en) 1999-03-31 2001-01-02 Glcosyn Pharmaceuticals, Inc. P-Boronophenylalanine complexes with fructose and related carbohydrates and polyols
GB0222945D0 (en) 2002-10-03 2002-11-13 Psimei Pharmaceuticals Plc Therapeutic compositions
JP5150084B2 (ja) 2006-10-17 2013-02-20 日本ケミカルリサーチ株式会社 高水溶性p−ボロノフェニルアラニン含有組成物
JP5345771B2 (ja) * 2007-08-27 2013-11-20 公立大学法人大阪府立大学 p−ボロノフェニルアラニンとソルビトールとを含有する液状組成物
JP2013173804A (ja) * 2013-06-14 2013-09-05 Osaka Prefecture Univ p−ボロノフェニルアラニンとソルビトールとを含有する液状組成物
RU2563211C2 (ru) 2013-10-02 2015-09-20 Государственное бюджетное образовательное учреждение высшего профессионального образования "Волгоградский государственный медицинский университет" Министерства здравоохранения Российской Федерации Фармацевтическая композиция в инъекционной форме с анальгетической активностью (варианты)

Also Published As

Publication number Publication date
EP4029505A4 (en) 2023-10-11
AR119936A1 (es) 2022-01-19
TW202114717A (zh) 2021-04-16
US12343354B2 (en) 2025-07-01
ES3024982T3 (en) 2025-06-05
CN114423458A (zh) 2022-04-29
EP4029505C0 (en) 2025-04-16
CA3151009A1 (en) 2021-03-18
US20220280540A1 (en) 2022-09-08
TWI905111B (zh) 2025-11-21
JPWO2021049520A1 (pl) 2021-03-18
WO2021049520A1 (ja) 2021-03-18
KR20220062367A (ko) 2022-05-16
JP2025015727A (ja) 2025-01-30
EP4029505B1 (en) 2025-04-16
AU2020347682B2 (en) 2025-08-28
EP4029505A1 (en) 2022-07-20
AU2020347682A1 (en) 2022-04-21

Similar Documents

Publication Publication Date Title
LT3801694T (lt) Automatinio įterpimo injektorius
CA184626S (en) Injection pen
CA187784S (en) Syringe
ES3065352T3 (en) Injection systems
GB2589548B (en) Auto-Injector
CA189000S (en) Injector cartridge
CA189001S (en) Injector cartridge
SG11201912186SA (en) Composition for injection
GB202015405D0 (en) No details
IL287021A (en) Injection device
IL279947A (en) Injection tool system
CA188999S (en) Injector cartridge
GB201917994D0 (en) Injection apparatus
GB201906941D0 (en) Injection device
EP4029505A4 (en) INJECTION CONTAINING P-BORONOPHENYLALANINE
GB2585141B (en) Syringe
GB2591977B (en) Auto-Injector
CA205592S (en) Injection device
CA186580S (en) Autoinjector
GB201910995D0 (en) DepthSet syringe
GB201913801D0 (en) Needle
GB201916328D0 (en) Disclosure
GB201916329D0 (en) Disclosure
GB201916327D0 (en) Disclosure
GB201912214D0 (en) Disclosure